Cannabinoid properties of methylfluorophosphonate analogs

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 3, 2000, Pages 1209-1218

  Martin, B R ^a   Beletskaya, I ^a   Patrick, G ^a   Jefferson, R ^a   Winckler, R ^a   Deutsch, D G ^a   Di Marzo, V ^a   Dasse, O ^a   Mahadevan, A ^a   Razdan, R K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID; METHYLARACHIDONYLFLUOROPHOSPHONATE; METHYLFLUOROPHOSPHONATE DERIVATIVE; O 1623; O 1624; O 1625; O 1626; O 1705; O 1778; O 1887; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ANALGESICS, OPIOID; ANIMALS; ARACHIDONIC ACIDS; BINDING, COMPETITIVE; BRAIN; CANNABINOIDS; CHROMATOGRAPHY, LIQUID; GLYCERIDES; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED ICR; PHOSPHONIC ACIDS; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SPINAL CORD; TIME FACTORS;

EID: 0033839170     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs
2. Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues
3. Brain regional distribution of endocannabinoids: Implications for their biosynthesis and biological function
4. Arachidanoylserotonin and other novel inhibitors of fatty acid amide hydrolase
5. Effects of anandamide on cannabinoid receptors in rat brain membranes
6. 9-tetrahdrocannabinol-induced responses and apparent agonist activity
7. The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity
8. Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities
9. Novel inhibitors of brain neuronal and basophilic anandamide amidohydrolase
10. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
11. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor
12. Methyl arachidonyl fluorophosphonate: A potent irreversible inhibitor of anandamide amidase
13. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
14. Biochemistry of the endogenous ligands of cannabinoid receptors
15. Evidence that methyl arachidonyl flourophosphate is an irreversible cannabinoid receptor antagonist
16. 9-tetrahydrocannabinol
17. Pharmacological activity of the cannabinoid recepter agonist, anandamide, a brain constituent
18. Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain
19. Functional identification of the active-site nucleophile of the human 85-kDa cytosolic phospholipase A2
20. Intrathecal morphine in mice: A new technique
21. Delta-9-THC training dose as a determinant for (R)-methanandamide generalization in rats
22. Acute and chronic cannabinoid effects: Characterization of precipitated withdrawal in dogs
23. Unique analogues of anandamide: Arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas
24. Identification of two serine residues involved in catalysis by fatty acid amide hydrolase
25. 14] as a substrate for anandamide amidase
26. Chemical and mutagenic investigations of fatty acid amide hydrolase: Evidence for a family of serine hydrolases with distinct catalytic properties
27. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia
28. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
29. Potent anandamide analogs: The effect of changing the length and branching of the end pentyl chain
30. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice
31. Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues
32. Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2
33. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist SR 141716
34. 9-THC-induced antinociception
35. Discriminative stimulus effects of anandamide in rats
36. Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in Rhesus monkeys
37. The biodisposition and metabolism of anandamide in mice